Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Minden

Showing results (111-120 of 308) with videos related to

Pageof 31
Sort By:
British Journal of Haematology|December 9, 2008
Outcomes of older patients (> or = 60 years) with acquired aplastic anaemia treated with immunosuppressive therapySusan Y Kao, Wei Xu, Joseph M Brandwein, et al.
Leukemia Research|April 10, 2025
Safety, tolerability, and pharmacokinetics of ASP1235 in relapsed or refractory acute myeloid leukemia: A phase 1 studyMonzr M Al Malki, Mark D Minden, Elizabeth Shima Rich, et al.
Oncotarget|March 10, 2016
Insulin receptor substrate 1 is a substrate of the Pim protein kinasesJin H Song, Sathish K R Padi, Libia A Luevano, et al.
Haematologica|February 24, 2022
Pseudo-mutant P53 is a unique phenotype of <i>DNMT3A</i>-mutated pre-leukemiaAmos Tuval, Yardena Brilon, Hadas Azogy, et al.
Blood|December 3, 2020
CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapyFraser Soares, Branson Chen, Jong Bok Lee, et al.
Journal of Geriatric Oncology|May 7, 2015
Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of ageShabbir M H Alibhai, Henriette Breunis, Narhari Timilshina, et al.
Leukemia & Lymphoma|August 19, 2007
Acute promyelocytic leukemia in patients aged 70 years and over -- a single center experience of unselected patientsPatricia Disperati, Mark D Minden, Vikas Gupta, et al.
Nature|January 21, 2011
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cellsFaiyaz Notta, Charles G Mullighan, Jean C Y Wang, et al.
Cancer Research|September 15, 2019
Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell MaintenanceMichelle Ly, Stefan Rentas, Ana Vujovic, et al.
American Journal of Hematology|January 4, 2012
Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemiaLalit Saini, Mark D Minden, Andre C Schuh, et al.
Pageof 31

Showing results (111-120 of 308) with videos related to

Sort By:
Pageof 31
British Journal of Haematology|December 9, 2008
Outcomes of older patients (> or = 60 years) with acquired aplastic anaemia treated with immunosuppressive therapySusan Y Kao, Wei Xu, Joseph M Brandwein, et al.
Leukemia Research|April 10, 2025
Safety, tolerability, and pharmacokinetics of ASP1235 in relapsed or refractory acute myeloid leukemia: A phase 1 studyMonzr M Al Malki, Mark D Minden, Elizabeth Shima Rich, et al.
Oncotarget|March 10, 2016
Insulin receptor substrate 1 is a substrate of the Pim protein kinasesJin H Song, Sathish K R Padi, Libia A Luevano, et al.
Haematologica|February 24, 2022
Pseudo-mutant P53 is a unique phenotype of <i>DNMT3A</i>-mutated pre-leukemiaAmos Tuval, Yardena Brilon, Hadas Azogy, et al.
Blood|December 3, 2020
CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapyFraser Soares, Branson Chen, Jong Bok Lee, et al.
Journal of Geriatric Oncology|May 7, 2015
Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of ageShabbir M H Alibhai, Henriette Breunis, Narhari Timilshina, et al.
Leukemia & Lymphoma|August 19, 2007
Acute promyelocytic leukemia in patients aged 70 years and over -- a single center experience of unselected patientsPatricia Disperati, Mark D Minden, Vikas Gupta, et al.
Nature|January 21, 2011
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cellsFaiyaz Notta, Charles G Mullighan, Jean C Y Wang, et al.
Cancer Research|September 15, 2019
Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell MaintenanceMichelle Ly, Stefan Rentas, Ana Vujovic, et al.
American Journal of Hematology|January 4, 2012
Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemiaLalit Saini, Mark D Minden, Andre C Schuh, et al.
Pageof 31